2325 — Yunkang Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapValue Trap

Annual cashflow statement for Yunkang, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	323	451	443	-86.8	-791
Depreciation
Amortisation
Non-Cash Items	3.5	40.1	503	102	624
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-163	-178	-965	250	353
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	203	369	137	334	259
Capital Expenditures	-176	-226	-318	-62.2	-30.5
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-15.2	537	-936	-91.7	384
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-191	311	-1,254	-154	354
Financing Cash Flow Items	-19.4	-21.4	717	-36.1	-47.6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	261	-215	1,102	276	-536
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	273	465	-13	456	77.2